Eugene William St. ClairMD
Dr. St.Clair currently serves as Chief of the Division of Rheumatology and Immunology at Duke University Medical Center where he is the W. Lester Brooks, Jr. Professor of Medicine. Dr. St.Clair’s primary research interests include the development of novel immunological therapies for Sjögren’s syndrome, rheumatoid arthritis, and systemic vasculitis. He has authored over 200 peer-reviewed articles, book chapters, and reviews Dr. St.Clair has served for more than 10 years as the Deputy Director of the Immune Tolerance Network, a NIAID-funded consortium dedicated to the development of tolerance-inducing therapies in transplantation, allergy and asthma, and autoimmunity. He is a former President of the American College of Rheumatology and has participated in the development of updated guidelines for the treatment of rheumatoid arthritis. He is a Founder of Rheos Medicines, Inc., a new company pioneering drug discovery in immunometabolism.